Marboquin™ (marbofloxacin) Tablets

Marboquin™ (marbofloxacin) Tablets
25mg, 1 count - tablet
25mg, 250 count - bottle
50mg, 1 count - tablet
50mg, 250 count - bottle
100mg, 1 count - tablet
100mg, 50 count - bottle
200mg, 1 count - tablet
200mg, 50 count - bottle
SKU : 21389_-RX
Price: $1.34

Treatment of infections in dogs and cats associated with bacteria susceptible to marbofloxacin

  • Available Sizes
    • 25mg, 1 count & 250 count
    • 50mg, 1 count & 250 count
    • 100mg, 1 count & 50 count
    • 200mg, 1 count & 50 count

200mg on Manufacturer Backorder; ETA Early December 2020

Description

Marboquin (marbofloxacin) tablets are indicated for the treatment of infections in dogs and cats associated with bacteria susceptible to marbofloxacin. Therapeutically equivalent to the pioneer drug so you can expect the same safety and efficacy at a substantially lower price. Available in 25 mg, 50 mg, 100 mg, and 200 mg scored tablets. 

Indications and Usage

Marboquin (marbofloxacin) tablets are indicated for the treatment of infections in dogs and cats associated with bacteria susceptible to marbofloxacin.

Contraindications

Marbofloxacin and other quinolones have been shown to cause arthropathy in immature animals of most species tested, the dog being particularly sensitive to this side effect. Marbofloxacin is contraindicated in immature dogs during the rapid growth phase (small and medium breeds up to 8 months of age, large breeds up to 12 months of age and giant breeds up to 18 months of age). Marbofloxacin is contraindicated in cats under 12 months of age. Marbofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones. 

Warning

For use in animals only. Keep out of reach of children. Avoid contact with eyes. In case of contact, immediately flush eyes with copious amounts of water for 15 minutes. In case of dermal contact, wash skin with soap and water. Consult a physician if irritation persists following ocular or dermal exposure. Individuals with a history of hypersensitivity to fluoroquinolones should avoid this product. In humans, there is a risk of user photosensitization within a few hours after excessive exposure to quinolones. If excessive accidental exposure occurs, avoid direct sunlight.

Precautions

Quinolones should be used with caution in animals with known or suspected central nervous system (CNS) disorders. In such animals, quinolones have, in rare instances, been associated with CNS stimulation which may lead to convulsive seizures. Quinolones have been shown to produce erosions of cartilage of weight-bearing joints and other signs of arthropathy in immature animals of various species. The use of fluoroquinolones in cats has been reported to adversely affect the retina. Such products should be used with caution in cats. The safety of marbofloxacin in animals used for breeding purposes, pregnant, or lactating has not been demonstrated.

Dosage and Administration

The recommended dosage for oral administration to dogs and cats is 1.25 mg marbofloxacin per lb of body weight once daily, but the dosage may be safely increased to 2.5 mg/lb. For the treatment of skin and soft tissue infections, Marboquin tablets should be given for 2-3 days beyond the cessation of clinical signs for a maximum of 30 days. For the treatment of urinary tract infections, Marboquin tablets should be administered for at least 10 days. If no improvement is noted within 5 days, the diagnosis should be re-evaluated and a different course of therapy considered.

Storage Conditions

Store at controlled room temperature, 68-77˚F (20-25˚C).

Customer Reviews
(0.00)
# of Ratings: 0
Loading...